Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Feb 27, 2024 £246.95 £250.00 £243.00 £248.50 41 436
Feb 26, 2024 £240.00 £247.00 £240.00 £247.00 19 360
Feb 23, 2024 £250.00 £255.55 £242.00 £247.00 24 923
Feb 22, 2024 £236.00 £244.00 £236.00 £244.00 59 456
Feb 21, 2024 £230.00 £239.50 £228.00 £229.00 66 669
Feb 20, 2024 £225.90 £228.00 £225.90 £227.00 14 676
Feb 19, 2024 £235.25 £235.25 £222.50 £222.50 1 007
Feb 16, 2024 £225.00 £234.00 £225.00 £230.50 31 183
Feb 15, 2024 £215.25 £222.50 £202.50 £219.50 71 291
Feb 14, 2024 £217.00 £225.38 £207.60 £218.50 61 588
Feb 13, 2024 £212.06 £228.50 £212.06 £228.00 28 524
Feb 12, 2024 £226.95 £226.95 £212.50 £221.50 18 488
Feb 09, 2024 £228.00 £228.00 £219.38 £222.00 18 425
Feb 08, 2024 £217.50 £227.68 £217.50 £221.00 37 755
Feb 07, 2024 £226.00 £227.85 £212.00 £218.00 99 513
Feb 06, 2024 £201.50 £219.00 £201.50 £215.00 158 913
Feb 05, 2024 £192.40 £199.24 £190.40 £192.40 41 172
Feb 02, 2024 £199.20 £199.80 £193.00 £193.00 24 849
Feb 01, 2024 £200.00 £210.75 £197.72 £202.00 65 364
Jan 31, 2024 £198.50 £204.00 £195.40 £196.60 55 739
Jan 30, 2024 £199.00 £206.00 £197.20 £200.50 102 612
Jan 29, 2024 £211.20 £211.20 £200.00 £205.50 110 867
Jan 26, 2024 £211.00 £211.00 £203.50 £205.00 140 238
Jan 25, 2024 £224.00 £224.00 £210.51 £217.50 35 481
Jan 24, 2024 £221.50 £223.50 £210.50 £214.50 90 583
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT